日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial

2022 年 AHA/ACC/HFSA 心力衰竭分期与糖尿病合并肾病患者心血管和肾脏结局之间的关联：SCORED 随机对照试验的事后分析

期刊:Circulation-Heart Failure
影响因子:8.4
doi:10.1161/CIRCHEARTFAILURE.125.013054
Odutayo, Ayodele; Bhatt, Deepak L; Sridhar, Vikas S; Szarek, Michael; Cannon, Christopher P; Leiter, Lawrence A; McGuire, Darren K; Lewis, Julia B; Lopes, Renato D; Scirica, Benjamin M; Ray, Kausik K; Davies, Michael J; Banks, Phillip; Girard, Manon; Verma, Subodh; Udell, Jacob A; Pitt, Bertram; Steg, Ph Gabriel; Cherney, David Z I
心血管
代谢
RED
糖尿病
心力衰竭
发表日期：2026
文献求助 收藏

Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM

二十碳五烯酸乙酯可降低心血管-肾脏-代谢综合征患者的心血管疾病风险：REDUCE-IT CKM

期刊:American Journal of Preventive Cardiology
影响因子:5.9
doi:10.1016/j.ajpc.2025.101387
Miller, Michael; Bhatt, Deepak L; Brinton, Eliot A; Jacobson, Terry A; Steg, Ph Gabriel; Ketchum, Steven B; Pineda, Armando Lira; Tardif, Jean-Claude; Ballantyne, Christie M
心血管疾病
心血管
代谢
RED
代谢综合征
发表日期：2026
文献求助 收藏

Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial

根据基线低密度脂蛋白胆固醇水平评估二十碳五烯酸乙酯治疗对心血管结局的影响：REDUCE-IT随机试验的二次分析

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.124.038656
Aggarwal, Rahul; Bhatt, Deepak L; Steg, Ph Gabriel; Miller, Michael; Brinton, Eliot A; Dunbar, Richard L; Ketchum, Steven B; Tardif, Jean-Claude; Martens, Fabrice M A C; Ballantyne, Christie M; Szarek, Michael; Mason, R Preston
RED
代谢
发表日期：2025
文献求助 收藏

Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial

使用阿利西尤单抗抑制PCSK9对可能患有家族性高胆固醇血症或III型高脂蛋白血症患者的影响：ODYSSEY OUTCOMES试验的结果

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.124.041190
Geba, Gregory P; Mohammadi, Kusha A; Damask, Amy; Paulding, Charles; Lotta, Luca A; Hindy, George; Pordy, Robert; Manvelian, Garen; Shapiro, Michael D; Bittner, Vera A; Bhatt, Deepak L; Szarek, Michael; Schwartz, Gregory G; Steg, Ph Gabriel; Fazio, Sergio
CSK
PCSK9
代谢
发表日期：2025
文献求助 收藏

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

急性冠脉综合征后使用二十碳五烯酸乙酯：REDUCE-IT 试验

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehad889
Sayah, Neila; Bhatt, Deepak L; Miller, Michael; Brinton, Eliot A; Jacobson, Terry A; Ketchum, Steven B; Jiao, Lixia; Pineda, Armando Lira; Doyle, Ralph T Jr; Tardif, Jean Claude; Ballantyne, Christie M; Steg, Ph Gabriel
RED
发表日期：2024
文献求助 收藏

Do patients benefit from omega-3 fatty acids?

患者能从ω-3脂肪酸中获益吗？

期刊:Cardiovascular Research
影响因子:13.3
doi:10.1093/cvr/cvad188
Sherratt, Samuel C R; Mason, R Preston; Libby, Peter; Steg, Ph Gabriel; Bhatt, Deepak L
代谢
发表日期：2024
文献求助 收藏

Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease

预测严重基线无症状颈动脉狭窄及其后续发生卒中和心血管疾病的风险

期刊:Stroke
影响因子:8.9
doi:10.1161/STROKEAHA.123.046894
Poorthuis, Michiel H F; Hageman, Steven H J; Fiolet, Aernoud T L; Kappelle, L Jaap; Bots, Michiel L; Steg, Ph Gabriel; Visseren, Frank L J; Bhatt, Deepak L; de Borst, Gert J
心血管疾病
心血管
发表日期：2024
文献求助 收藏

Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED Trial

索格列净对 2 型糖尿病合并慢性肾病患者的肾脏结局、肾功能和蛋白尿的影响：SCORED 试验的二次分析

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000000000414
Sridhar, Vikas S; Bhatt, Deepak L; Odutayo, Ayodele; Szarek, Michael; Davies, Michael J; Banks, Phillip; Pitt, Bertram; Steg, Ph Gabriel; Cherney, David Z I
糖尿病
RED
代谢
发表日期：2024
文献求助 收藏

Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES

阿利西尤单抗治疗急性冠脉综合征后胸痛：ODYSSEY OUTCOMES 研究分析

期刊:American Journal of Preventive Cardiology
影响因子:5.9
doi:10.1016/j.ajpc.2024.100900
Geba, Gregory P; Chen, Ruifeng; Talapatra, Kasturi; Brackin, Taylor; Mohammadi, Kusha A; Pordy, Robert; Manvelian, Garen; Maron, David J; Schwartz, Gregory G; Szarek, Michael; Steg, Ph Gabriel; Fazio, Sergio
发表日期：2024
文献求助 收藏

Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

急性冠脉综合征后，他汀类药物和阿利西尤单抗可短暂地使低密度脂蛋白胆固醇水平降至极低，这与心血管风险降低相关：ODYSSEY OUTCOMES 试验

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehad144
Schwartz, Gregory G; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Bujas-Bobanovic, Maja; Diaz, Rafael; Fazio, Sergio; Fras, Zlatko; Goodman, Shaun G; Harrington, Robert A; Jukema, J Wouter; Manvelian, Garen; Pordy, Robert; Ray, Kausik K; Scemama, Michel; White, Harvey D; Steg, Ph Gabriel
代谢
发表日期：2023
文献求助 收藏